GRIFOLS | GRF - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Alcon AG USD 882M 19M 2026-03
Amadeus IT EUR 497.5M 206.6M 2025-03
Amarin USD 18.97M 1.03M 2025-12
argenx SE USD 355M 74.62M 2026-03
AstraZeneca USD 5.06B 455M 2026-03
Bayer EUR 3.7B 356M 2026-03
Cie Automotive EUR 315.66M 28.06M 2024-12
Demant DKK 6.09B 135M 2025-12
Ence Energia y Celulosa EUR 29.1M 2M 2024-09
Essilor EUR 5.62B 4.53B 2025-12
Ferrovial EUR 906M 52M 2024-12
Fresenius EUR 819M 143M 2025-12
Fresenius Medical Care EUR 749M 36M 2026-03
Genmab DKK 208M 60M 2025-12
GlaxoSmithKline GBP 2.12B 558M 2026-03
GRIFOLS EUR 281M 5.7M 2026-03
Hikma Pharmaceutical USD 288M 149M 2025-12
Inditex EUR 2.51B 7.98B 2025-01
Lakefront Biotherapeutics EUR 35.5M 8.91M 2026-03
Merck EUR 1.52B 80M 2026-03
Novartis USD 3.14B 296M 2026-03
Philips EUR 1.18B 121M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.33B 419M 2026-03
Smith & Nephew USD 1.42B 65M 2025-12
UCB EUR 1.47B 193M 2025-12
Viscofan EUR 72.59M 4.52M 2025-03